FNArena Windows

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

ASX CODE LAST PRICE % MOVE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET UPSIDE/DOWNSIDE
CLV $0.56

-1.77%

$0.60 $0.34 13.9

$0.68

22.5%

EBO $27.65

-1.43%

$38.23 $27.65 19.1

$34.873

26.1%

EXL $0.02 0.00% $0.05 $0.00

MCP $0.27

-3.57%

$0.43 $0.21

SIG $3.04

0.33%

$3.32 $1.26 49.1

$3.057

0.6%

Previous Stories
Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes

Sep 10 2012

Weekly update on recommendation, target price, and earnings forecast changes.


Treasure Chest: Special Dividend From Sigma?

Jul 26 2012

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Given excess cash on the books Citi is anticipating a special dividend from Sigma, offering an attractive net yield.


Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes

Jun 04 2012

Weekly update on recommendation, target price, and earnings forecast changes.


Sigma Has Excess Cash, But With Ongoing Risks

Mar 26 2012

Sigma’s full year result showed improvement in many metrics but a tough industry outlook and a lack of compelling value are keeping brokers from taking a more positive view.


Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes

Sep 26 2011

Weekly update on recommendation, target price, and earnings forecast changes.


Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes

Sep 19 2011

Weekly update on recommendation, target price, and earnings forecast changes.


Morgan Stanley Breaks Consensus And Says Buy Sigma

Jun 02 2011

While brokers in the FNArena databse favour Sell ratings on Sigma Pharmaeceutical, Morgan Stanley has gone against the trend and upgraded to an Overweight rating.


REPEAT Rudi’s View: The Divide Between Uncertainty And Value

Jun 28 2010

With 48 ASX200 companies now trading on single digit FY11 multiples, is there “value” in the Australian share market?


The Monday Report

Mar 22 2010

A wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead.


API Surprises, But Brokers Non-Enthusiastic

Oct 22 2009

Most Australian stockbrokers simply cannot get excited about Australian Pharmaceutical Industries.